Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update.

IF 2.7 3区医学 Q2 UROLOGY & NEPHROLOGY Peritoneal Dialysis International Pub Date : 2024-09-01 DOI:10.1177/08968608241274096

Bradley A Warady, Rebecca Same, Dagmara Borzych-Duzalka, Alicia M Neu, Ibrahim El Mikati, Reem A Mustafa, Brandy Begin, Peter Nourse, Sevcan A Bakkaloglu, Vimal Chadha, Francisco Cano, Hui Kim Yap, Qian Shen, Jason Newland, Enrico Verrina, Ann L Wirtz, Valerie Smith, Franz Schaefer

{"title":"Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update.","authors":"Bradley A Warady, Rebecca Same, Dagmara Borzych-Duzalka, Alicia M Neu, Ibrahim El Mikati, Reem A Mustafa, Brandy Begin, Peter Nourse, Sevcan A Bakkaloglu, Vimal Chadha, Francisco Cano, Hui Kim Yap, Qian Shen, Jason Newland, Enrico Verrina, Ann L Wirtz, Valerie Smith, Franz Schaefer","doi":"10.1177/08968608241274096","DOIUrl":null,"url":null,"abstract":"<p><p>Infection-related complications remain the most significant cause for morbidity and technique failure in infants, children and adolescents who receive maintenance peritoneal dialysis (PD). The 2024 update of the Clinical Practice Guideline for the Prevention and Management of Peritoneal Dialysis Associated Infection in Children builds upon previous such guidelines published in 2000 and 2012 and provides comprehensive treatment guidance as recommended by an international group of pediatric PD experts based upon a review of published literature and pediatric PD registry data. The workgroup prioritized updating key clinical issues contained in the 2012 guidelines, in addition to addressing additional questions developed using the PICO format. A variety of new guideline statements, highlighted by those pertaining to antibiotic therapy of peritonitis as a result of the evolution of antibiotic susceptibilities, antibiotic stewardship and clinical registry data, as well as new clinical benchmarks, are included. Recommendations for future research designed to fill important knowledge gaps are also provided.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Peritoneal Dialysis International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08968608241274096","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Infection-related complications remain the most significant cause for morbidity and technique failure in infants, children and adolescents who receive maintenance peritoneal dialysis (PD). The 2024 update of the Clinical Practice Guideline for the Prevention and Management of Peritoneal Dialysis Associated Infection in Children builds upon previous such guidelines published in 2000 and 2012 and provides comprehensive treatment guidance as recommended by an international group of pediatric PD experts based upon a review of published literature and pediatric PD registry data. The workgroup prioritized updating key clinical issues contained in the 2012 guidelines, in addition to addressing additional questions developed using the PICO format. A variety of new guideline statements, highlighted by those pertaining to antibiotic therapy of peritonitis as a result of the evolution of antibiotic susceptibilities, antibiotic stewardship and clinical registry data, as well as new clinical benchmarks, are included. Recommendations for future research designed to fill important knowledge gaps are also provided.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

预防和管理儿童腹膜透析相关感染的临床实践指南：2024 年更新版。

感染相关并发症仍然是导致接受维持性腹膜透析（PD）的婴儿、儿童和青少年发病和技术失败的最主要原因。儿童腹膜透析相关感染的预防和管理临床实践指南》2024 年更新版以 2000 年和 2012 年发布的此类指南为基础，并根据国际儿科腹膜透析专家小组在回顾已发表文献和儿科腹膜透析登记数据后提出的建议，提供了全面的治疗指导。工作组优先更新了 2012 年指南中包含的关键临床问题，此外还解决了使用 PICO 格式提出的其他问题。其中包括各种新的指南声明，重点是由于抗生素敏感性、抗生素管理和临床登记数据的演变而导致的腹膜炎抗生素治疗，以及新的临床基准。此外，还提供了旨在填补重要知识空白的未来研究建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Peritoneal Dialysis International 医学-泌尿学与肾脏学

CiteScore

6.00

自引率

17.90%

发文量

审稿时长

6-12 weeks

期刊介绍： Peritoneal Dialysis International (PDI) is an international publication dedicated to peritoneal dialysis. PDI welcomes original contributions dealing with all aspects of peritoneal dialysis from scientists working in the peritoneal dialysis field around the world. Peritoneal Dialysis International is included in Index Medicus and indexed in Current Contents/Clinical Practice, the Science Citation Index, and Excerpta Medica (Nephrology/Urology Core Journal). It is also abstracted and indexed in Chemical Abstracts (CA), as well as being indexed in Embase as a priority journal.